Interview Interview Expert talks and scientific presentations by local and international clinicians and scientists. Published: Jun 25, 2019

Amyotrophic lateral sclerosis (ALS): Current and Emerging Treatment Landscape

More than 20 years after the first-drug was approved for the treatment of ALS, new and emerging therapies are changing the treatment landscape of ALS.

Dr. Raghav Govindarajan has a working relationship with the companies listed:
AbbVie Inc., Alexion Pharma, Mitsubishi Tanabe Pharma

Learn more

Movement Disorders Neuromuscular amyotrophic lateral sclerosis motor neuron disease treatment Motor neuron amyotrophic lateral sclerosis (ALS) ALS amyotrophic Amyotrophic lateral